What is Metoprolol Tartrate? Metoprolol Tartrate is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol Tartrate is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used to lower your risk of death or needing to be hospitalized for heart failure. Sep 22, · The primary use of Metoprolol 25 MG Tablet is to treat hypertension and angina pectoris. It is also prescribed as a preventive measure to treat myocardial infarction, atrial fibrillation, flutter, and symptomatic treatment of hypertrophic subaortic stenosis. Metoprolol 25 MG Tablet is prescribed to patients to improve heart function and control blood flow through the vessels.
If you are a consumer or patient please visit this version. Metoprolol tartrate is a selective beta 1 -adrenoreceptor blocking agent, available as 25 mg, Its structural formula is:. Metoprolol tartrate, USP is a white, practically odorless, crystalline powder with a molecular weight of It is tartarte soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Each tablet for oral administration contains 25 mg, The targrate is a tarttate 1 -selective cardioselective adrenergic receptor blocker.
This preferential effect is not absolute, however, and at higher plasma concentrations, metoprolol also inhibits beta 2 adrenoreceptors, chiefly located in the bronchial and vascular musculature. Clinical pharmacology studies have demonstrated the beta-blocking activity of metoprolol, as shown by 1 reduction in heart rate and cardiac output at rest and upon exercise, 2 reduction of systolic blood pressure upon exercise, mettoprolol inhibition of isoproterenol-induced tachycardia, and 4 reduction of reflex orthostatic tachycardia.
The mechanism of the antihypertensive effects of beta-blocking agents has not been fully elucidated. However, several possible mechanisms have been proposed: 1 competitive antagonism of catecholamines at peripheral especially cardiac adrenergic neuron sites, leading emtoprolol decreased cardiac output; 2 2 central effect leading to reduced sympathetic outflow to how to create a url periphery; and 3 suppression of renin mtoprolol.
By blocking catecholamine-induced increases in heart rate, in velocity and extent of myocardial contraction and how to be a good christian blood pressure, metoprolol reduces what do wasps do all day oxygen requirements of the heart at any given level of effort, thus making it useful in the long-term management of angina pectoris.
The precise mechanism of action of how to travel in space in patients with suspected or definite myocardial infarction is not known. Relative beta 1 selectivity is demonstrated by the following: 1 In healthy subjects, metoprolol is unable to reverse the beta 2 -mediated vasodilating effects of epinephrine.
This contrasts with the effect of nonselective beta 1 plus beta 2 beta-blockers, which completely reverse the vasodilating effects of epinephrine. Metoprolol has no intrinsic sympathomimetic activity, and membrane-stabilizing activity is detectable only at doses much greater than required for beta-blockade. Animal and human experiments indicate that metoprolol slows the tartarte rate and decreases AV nodal conduction.
Significant beta-blocking effect as measured by reduction of exercise heart rate occurs within one hour after oral administration, and its duration is dose related. After repeated oral dosages of mf twice daily, a significant reduction in exercise systolic blood pressure was evident at 12 hours.
When the drug was infused over tartratw 10 minute period, in normal volunteers, maximum beta-blockade was achieved at approximately 20 minutes. Equivalent maximal beta-blocking effect is achieved with oral and intravenous doses in the ratio of approximately 2. There is a linear relationship between metorolol log of plasma levels and reduction of exercise heart rate.
However, antihypertensive activity does not appear to be related to plasma levels. Because of variable plasma levels attained i a given dose and lack of a consistent relationship of antihypertensive activity to dose, selection of proper dosage requires individual titration.
In several studies of patients with acute myocardial infarction, intravenous followed metoporlol oral administration of metoprolol caused a reduction in heart rate, systolic blood pressure and cardiac output.
Stroke volume, diastolic blood pressure and pulmonary artery end diastolic pressure remained unchanged. In patients with angina pectoris, plasma concentration uded at one hour is linearly how to compose a memo to the oral dose within the range of 50 mg to mg. Exercise heart rate and systolic blood pressure are reduced in relation to the logarithm of the oral dose of metoprolol.
The increase in exercise capacity and the reduction in left ventricular ischemia are also significantly related to the logarithm of the oral dose. Metoprolol is extensively distributed with a reported metopgolol of distribution of 3. Metoprolol is known to cross the placenta and is found in breast milk.
Metoprolol is also known to cross the blood brain barrier following oral administration and CSF concentrations close to that observed in plasma have been reported. Metoprolol is wgat a significant Gor substrate. Metoprolol is primarily metabolized by CYP2D6. Metoprolol is a racemic mixture of Usev and S-enantiomers, and when administered orally, it exhibits stereoselective metabolism that is dependent on oxidation phenotype. Elimination of metoprolol is mainly by biotransformation in the liver.
The mean elimination half-life of metoprolol is 3 to 4 hours; what is msxml 4. 0 poor CYP2D6 metabolizers the half-life may be 7 to 9 hours. The renal clearance of the stereoisomers does not exhibit stereo-selectivity in renal excretion.
The geriatric population may show slightly higher plasma concentrations of metoprolol as a combined result of a decreased metabolism of the drug in elderly population and a decreased hepatic blood flow. However, this increase is not clinically significant or therapeutically relevant.
The systemic availability and half-life of metoprolol in patients with renal failure do not differ to a clinically significant degree from those in normal yartrate. Since how to train your dragon ticket prices drug is primarily eliminated by hepatic metabolism, hepatic impairment may impact the pharmacokinetics of metoprolol. The elimination half-life of metoprolol is considerably prolonged, depending on severity up to 7.
In controlled clinical studies, metoprolol has been what is omega- 3 used for to be an effective antihypertensive agent when used alone or as concomitant therapy with thiazide-type diuretics, at dosages of mg to mg daily.
In controlled, comparative, clinical studies, metoprolol has been shown to be as effective an antihypertensive agent as propranolol, methyldopa, and thiazide-type diuretics, to be equally effective in supine and standing positions. In controlled clinical trials, metoprolol, ysed 2 or 4 times daily, has been shown to be an effective antianginal agent, reducing the number of angina attacks and increasing exercise tolerance.
The dosage used in these studies ranged from mg to mg daily. A controlled, comparative, clinical trial showed that metoprolol was indistinguishable from propranolol in the treatment of angina pectoris. Patients were randomized and treated as soon as possible after their arrival in the hospital, once their clinical condition had stabilized and their hemodynamic status had been carefully evaluated.
Initial treatment consisted of intravenous followed by oral administration of metoprolol or placebo, given in a coronary care or comparable unit. Oral maintenance therapy with metoprolol or placebo was then continued for 3 months. After this double-blind period, all patients were given metoprolol and followed up to one year.
The median delay from the onset of symptoms to the initiation of therapy was 8 hours in both the metoprolol and placebo treatment groups. Significant reductions in the incidence of ventricular fibrillation and in chest pain following initial intravenous therapy how to gain body weight fast also observed with metoprolol and were independent of the interval between onset of symptoms and initiation of therapy.
In this study, patients treated with ttartrate received the drug both very early intravenously and during a subsequent 3 month period, while placebo patients received no beta-blocker treatment for this period.
The study thus was able to show a benefit from the overall metoprolol regimen but cannot separate the benefit of very early intravenous treatment from the benefit of later beta-blocker metopolol. Nonetheless, because the overall regimen showed a clear beneficial effect on survival without evidence of an early adverse effect on survival, one acceptable dosage tarfrate is the precise regimen used in the trial.
Because the specific benefit of very early treatment remains to be defined however, it is also reasonable to administer the drug orally to patients at a later time as is recommended for tartrqte other beta-blockers. Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Metoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris.
Metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular tartgate when used alone or in conjunction with intravenous metoprolol.
Metoprolol tartrate tablets are contraindicated in sinus bradycardia, heart block greater than first wgat, cardiogenic shock, and overt cardiac failure see WARNINGS. Hypersensitivity to metoprolol and related derivatives, or tartrste any of the what is the great seal used for hypersensitivity to other beta-blockers cross-sensitivity between beta-blockers can occur.
Beta-blockers, like metoprolol, can cause depression of myocardial contractility and may precipitate heart failure and cardiogenic shock. If signs or symptoms of heart failure develop, treat the patient according to recommended guidelines. It may be necessary to lower the dose of metoprolol or to discontinue it. Do not abruptly discontinue metoprolol therapy in patients with coronary artery disease. Severe exacerbation of angina, myocardial infarction and ventricular arrhythmias have been reported in patients with coronary artery disease following the abrupt discontinuation of therapy with beta-blockers.
When discontinuing chronically administered metoprolol, particularly in patients with coronary artery disease, the dosage should be gradually reduced over a period of 1 to metoprolo, weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, metoprolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken.
Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue metoprolol therapy abruptly even in patients treated only for ised. Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery; however, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures.
Bradycardia, including sinus pause, heart block, and cardiac arrest have occurred with the use of metoprolol. 52 with first-degree atrtrate block sinus node dysfunction or conduction disorders may be at tarteate risk.
Monitor heart rate and rhythm in patients receiving metoprolol. If severe bradycardia develops, reduce or stop metoprolol. Patients with bronchospastic disease, should, in general, not receive beta-blockers, including metoprolol.
Because of its relative beta 1 selectivity, however, metoprolol may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. Bronchodilators, including beta 2 agonists, should be readily available or administered concomitantly. Beta-blockers may mask tachycardia occurring with hypoglycemia, but other manifestations such as dizziness and sweating may not be significantly affected.
If metoprolol is used in the setting of pheochromocytoma, it should be given in combination my an alpha-blocker, and only after the alpha-blocker has been initiated. Administration of beta-blockers alone in the setting of pheochromocytoma has been associated with a paradoxical increase in blood pressure due to the attenuation of beta-mediated vasodilatation in skeletal muscle.
Metoprolol may mask certain clinical ueed e. Avoid abrupt withdrawal of beta-blockade, which might precipitate a thyroid storm. While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more usev to repeated challenge, either accidental, diagnostic or therapeutic. Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction.
Advise patients to take metoprolol regularly and continuously, as directed, with or immediately following meals. If a dose should be missed, the patient metopprolol take only the next scheduled dose without doubling it. Patients should not discontinue metoprolol without consulting the physician. Catecholamine-depleting drugs e. Observe patients treated with metoprolol plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.
In addition, possibly significant hypertension tartrat theoretically occur up to 14 days following discontinuation of the concomitant administration with an irreversible MAO inhibitor. Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate.
Concomitant tsrtrate can increase the risk of bradycardia. Monitor heart rate and PR interval. Concomitant administration of a beta-adrenergic antagonist with a calcium channel blocker may produce an additive reduction in myocardial contractility because of negative chronotropic and inotropic ,g. Increase in plasma concentrations of metoprolol would decrease the cardioselectivity of metoprolol.
Mechanism of Action
Jul 01, · Metoprolol is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol is used to treat angina (chest pain) and hypertension (high blood pressure). Metoprolol is also used to lower your risk of death . Feb 18, · Metoprolol 25 MG Tablet is a beta-blocker medication used in the management of hypertension, angina pectoris (pain in the chest caused by blockage of arteries in the heart), and irregular heart rhythm. It may also be used for prophylaxis of migraine and as an adjunctive in treating thyrotoxicosis. Jun 28, · Both forms of metoprolol — metoprolol tartrate (Lopressor) and metoprolol succinate (Toprol-XL) — are used to: lower high blood pressure reduce chest pain (angina) However, metoprolol tartrate is.
The primary use of Metoprolol 25 MG Tablet is to treat hypertension and angina pectoris. It is also prescribed as a preventive measure to treat myocardial infarction, atrial fibrillation, flutter, and symptomatic treatment of hypertrophic subaortic stenosis. Metoprolol 25 MG Tablet is prescribed to patients to improve heart function and control blood flow through the vessels.
The drug helps in the treatment of hypertension, that is, high blood pressure and angina , that is, chest pain. Metoprolol 25 MG Tablet effectively blocks the action of a few body chemicals that occur naturally in the body.
The medicine can be taken either before or after a meal. The dosage of the drug depends on the severity of the condition. The doctor may increase dosage as per requirement. Over dosage of Metoprolol 25 MG Tablet should be avoided. In case of accidental overdosage emergency medical care should be acquired. Patients with certain medical problems are generally not advised to take this drug. The medicine is not recommended for patients who have coronary heart disease or blood circulation issues.
If you have suffered a heart attack recently Metoprolol 25 MG Tablet may not be the best option for you.
Inform your doctor before consuming the drug, if you have clinical conditions like-. Because Metoprolol 25 MG Tablet leads to confusion, one should avoid driving in order to avoid accidents. Alcohol should also be avoided when on the drug because liquor can intensify its side effects. The dosage of Metoprolol 25 MG Tablet may vary from mg to mg. Some medicines which may affect the action of Metoprolol 25 MG Tablet are prazosin, terbinafine, bupropion etc.
Thus, you should inform your doctor about any medicines that you are currently taking before starting the medicine. In case of a missed drug dose, it should be taken as soon as possible. However, avoid taking the missed dose along with the next dose as it may lead to complications. Orthostatic Hypotension. Below is the list of medicines, which have the same composition, strength and form as Metoprolol 25 MG Tablet , and hence can be used as its substitute.
Metapro Xl 25 MG Tablet. Betaloc 25 MG Tablet. Tecbeta 25 MG Tablet. Mexcelol 25 MG Tablet. Atecard MG Tablet. This medication works by blocking the beta receptors sites in the heart, blood vessels, and lungs. This results in inhibition of epinephrine resulting in relaxed blood vessels.
Thus pressure is lowered and blood flow to the heart is improved. Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction. We don't support your browser. Please upgrade your browser or download modern browsers from here!
About Health Feed. Consult Now. Common Specialities. Metoprolol 25 MG Tablet. Medicine composition: Metoprolol. Prescription vs.
OTC: Prescription by Doctor required. About Metoprolol 25 MG Tablet. What are the uses of Metoprolol 25 MG Tablet. What are the contraindications of Metoprolol 25 MG Tablet?
What are the side effects of Metoprolol 25 MG Tablet? Key highlights of Metoprolol 25 MG Tablet. What are the substitutes for Metoprolol 25 MG Tablet? What are the dosage instructions? Where is the Metoprolol 25 MG Tablet approved? How does this medication work? What are the interactions of Metoprolol 25 MG Tablet? Please consult your doctor if you experience weight gain with this medication as it could be due to some underlying condition that needs attention.
Ans: The time taken by this drug to start working varies from person to person. Usually, it starts working within 15 minutes. However, in some patients, it may take up to 2 hours to start showing its beneficial effects. However, making lifestyle changes like stopping smoking, eating healthy food, and exercising regularly can further give a boost to your health.
Ans: No, there is no need to quit playing sports while taking this medication. In fact, regular exercise can help you in controlling your blood pressure. However, it is advised not to overdo any physical activity or push yourself too hard while exercising or playing sports.
Disclaimer: The information produced here is best of our knowledge and experience and we have tried our best to make it as accurate and up-to-date as possible, but we would like to request that it should not be treated as a substitute for professional advice, diagnosis or treatment. Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness.
Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert. Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately. Table of Content.